This information is for educational purposes only. It is not intended as medical advice. Always consult a qualified healthcare professional.
OTC
Tacrolimus
1 mg/1, Capsule, extended release
INN: TACROLIMUS
Data updated: 2026-04-25
Available in:
🇨🇿🇩🇪🇬🇧🇯🇵🇷🇴🇸🇰
Form
CAPSULE, EXTENDED RELEASE
Dosage
1 mg/1
Route
ORAL
Storage
—
About This Product
User Reviews
Reviews reflect personal experiences and are not medical advice. Always consult your doctor.
Manufacturer
Amneal Pharmaceuticals NY LLC
ATC Code
D11AH01
Source
OPENFDA_NDC
(
ARTG
)
Tacrolimus Intas 0.1% ointment is indicated for the treatment of moderate to severe atopic dermatitis in adults and adolescents (16 years of age and above).,Flare treatment,Treatment of moderate to severe flares of atopic dermatitis in patients who are not adequately responsive to or are intolerant of conventional therapies such as topical corticosteroids.,Maintenance treatment,Prevention of flares and prolongation of flare-free intervals in patients experiencing a high frequency of disease exacerbations who have responded to tacrolimus treatment during flares.
⚠️ Warnings
• Caution should be exercised in patients with heart, kidney or liver disease, any allergy, who are taking other medications, elderly, children, during pregnancy and breastfeeding.
• Patient may develop with increased risk of skin cancer; avoid exposure to sunlight.
• Wear protective clothing and sunscreen with a high skin protection factor (SPF) to avoid sunburn.
• Wear sunglasses avoid eye damage.
• It may increase blood pressure; monitor blood pressure level regularly while taking this medication.
• Patient may experience with the following symptoms: thirst, excessive hunger, frequent urination, blurred vision and confusion.
• Avoid vaccination while taking this medication.